IL140249A0 - Muscarinic antagonists - Google Patents
Muscarinic antagonistsInfo
- Publication number
- IL140249A0 IL140249A0 IL14024999A IL14024999A IL140249A0 IL 140249 A0 IL140249 A0 IL 140249A0 IL 14024999 A IL14024999 A IL 14024999A IL 14024999 A IL14024999 A IL 14024999A IL 140249 A0 IL140249 A0 IL 140249A0
- Authority
- IL
- Israel
- Prior art keywords
- muscarinic antagonists
- muscarinic
- antagonists
- Prior art date
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
- 239000003149 muscarinic antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10798398A | 1998-06-30 | 1998-06-30 | |
| PCT/US1999/012821 WO2000000488A1 (en) | 1998-06-30 | 1999-06-28 | Muscarinic antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL140249A0 true IL140249A0 (en) | 2002-02-10 |
Family
ID=22319562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14024999A IL140249A0 (en) | 1998-06-30 | 1999-06-28 | Muscarinic antagonists |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1091956B1 (de) |
| JP (1) | JP3344997B2 (de) |
| KR (1) | KR20010053254A (de) |
| CN (1) | CN1146559C (de) |
| AR (1) | AR019167A1 (de) |
| AT (1) | ATE272632T1 (de) |
| AU (1) | AU756484B2 (de) |
| CA (1) | CA2336000C (de) |
| DE (1) | DE69919171T2 (de) |
| ES (1) | ES2221399T3 (de) |
| HU (1) | HUP0104058A2 (de) |
| IL (1) | IL140249A0 (de) |
| MY (1) | MY133108A (de) |
| NZ (1) | NZ508910A (de) |
| TW (1) | TW474933B (de) |
| WO (1) | WO2000000488A1 (de) |
| ZA (1) | ZA200007555B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6689765B2 (en) | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
| TR200103214T2 (tr) * | 1999-05-04 | 2002-03-21 | Schering Corporation | CCR5 antagonistleri olarak yararlì piperazin trevleri. |
| US6391865B1 (en) | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
| US6635646B1 (en) | 1999-05-04 | 2003-10-21 | Schering Corporation | Pegylated interferon alfa-CCR5 antagonist combination HIV therapy |
| US6294554B1 (en) | 1999-09-22 | 2001-09-25 | Schering Corporation | Muscarinic antagonists |
| CN1167682C (zh) * | 1999-09-22 | 2004-09-22 | 先灵公司 | 毒蕈碱拮抗剂 |
| AR033517A1 (es) | 2000-04-08 | 2003-12-26 | Astrazeneca Ab | Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos |
| MXPA03008356A (es) | 2001-03-13 | 2003-12-11 | Schering Corp | Compuestos del tipo no imidazol como antagonistas de histamina h3. |
| EP1604982A1 (de) | 2001-07-02 | 2005-12-14 | AstraZeneca AB | Zwischenverbindungen für die herstellung von piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen |
| GB0120461D0 (en) | 2001-08-22 | 2001-10-17 | Astrazeneca Ab | Novel compounds |
| GB0122503D0 (en) | 2001-09-18 | 2001-11-07 | Astrazeneca Ab | Chemical compounds |
| SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0202838D0 (sv) * | 2002-09-24 | 2002-09-24 | Astrazeneca Ab | Chemical compounds |
| SE0300957D0 (sv) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
| TW200722419A (en) * | 2005-05-27 | 2007-06-16 | Astrazeneca Ab | Chemical compounds |
| WO2006126948A1 (en) * | 2005-05-27 | 2006-11-30 | Astrazeneca Ab | Piperidines for the treatment of chemokine mediated diseases |
| BRPI0613563A2 (pt) | 2005-07-21 | 2012-01-17 | Astrazeneca Ab | novos derivados de piperidina |
| EP2137162B1 (de) * | 2007-03-15 | 2018-08-01 | Novartis AG | Organische verbindungen und anwendungen davon |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| CN104356056B (zh) * | 2014-11-19 | 2017-04-05 | 南京华威医药科技开发有限公司 | 吡仑帕奈中间体的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
-
1999
- 1999-06-28 CN CNB998100765A patent/CN1146559C/zh not_active Expired - Fee Related
- 1999-06-28 WO PCT/US1999/012821 patent/WO2000000488A1/en not_active Ceased
- 1999-06-28 TW TW088110871A patent/TW474933B/zh not_active IP Right Cessation
- 1999-06-28 NZ NZ508910A patent/NZ508910A/xx unknown
- 1999-06-28 EP EP99931768A patent/EP1091956B1/de not_active Expired - Lifetime
- 1999-06-28 AU AU48201/99A patent/AU756484B2/en not_active Ceased
- 1999-06-28 IL IL14024999A patent/IL140249A0/xx unknown
- 1999-06-28 KR KR1020007014935A patent/KR20010053254A/ko not_active Withdrawn
- 1999-06-28 AR ARP990103104A patent/AR019167A1/es unknown
- 1999-06-28 HU HU0104058A patent/HUP0104058A2/hu unknown
- 1999-06-28 CA CA002336000A patent/CA2336000C/en not_active Expired - Fee Related
- 1999-06-28 DE DE69919171T patent/DE69919171T2/de not_active Expired - Lifetime
- 1999-06-28 MY MYPI99002663A patent/MY133108A/en unknown
- 1999-06-28 JP JP2000557249A patent/JP3344997B2/ja not_active Expired - Fee Related
- 1999-06-28 ES ES99931768T patent/ES2221399T3/es not_active Expired - Lifetime
- 1999-06-28 AT AT99931768T patent/ATE272632T1/de not_active IP Right Cessation
-
2000
- 2000-12-15 ZA ZA200007555A patent/ZA200007555B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2221399T3 (es) | 2004-12-16 |
| ZA200007555B (en) | 2002-03-15 |
| HUP0104058A2 (hu) | 2002-03-28 |
| AR019167A1 (es) | 2001-12-26 |
| DE69919171D1 (de) | 2004-09-09 |
| AU756484B2 (en) | 2003-01-16 |
| ATE272632T1 (de) | 2004-08-15 |
| EP1091956B1 (de) | 2004-08-04 |
| CN1314905A (zh) | 2001-09-26 |
| NZ508910A (en) | 2003-01-31 |
| CN1146559C (zh) | 2004-04-21 |
| CA2336000C (en) | 2006-10-10 |
| MY133108A (en) | 2007-10-31 |
| AU4820199A (en) | 2000-01-17 |
| TW474933B (en) | 2002-02-01 |
| CA2336000A1 (en) | 2000-01-06 |
| JP3344997B2 (ja) | 2002-11-18 |
| EP1091956A1 (de) | 2001-04-18 |
| KR20010053254A (ko) | 2001-06-25 |
| DE69919171T2 (de) | 2005-08-04 |
| JP2002519349A (ja) | 2002-07-02 |
| WO2000000488A1 (en) | 2000-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL128409A0 (en) | Muscarinic antagonists | |
| PL348375A1 (en) | Pyrrolidine derivatives-ccr-3 receptor antagonists | |
| SG80041A1 (en) | Muscarinic receptor antagonists | |
| AU2002235224A1 (en) | Muscarinic antagonists | |
| PL346247A1 (en) | Muscarinic agonists and antagonists | |
| HUP0101753A3 (en) | Boring-tool | |
| IL137329A0 (en) | Vla-4 antagonists | |
| PL346396A1 (en) | Preparation agents | |
| AU5786300A (en) | Muscarinic antagonists | |
| AU137693S (en) | Sawhorse | |
| GB9816729D0 (en) | Substituted cyclohexylaminopyrimidines | |
| PL347397A1 (en) | Substituted 3-aryl-pyrazoles | |
| GB9818418D0 (en) | Sub | |
| AU5112699A (en) | 5-HT1f antagonists | |
| HUP0102476A3 (en) | Substituted cyclooctadepsipeptides | |
| GB9911456D0 (en) | Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives | |
| HK1032395A (en) | Muscarinic antagonists | |
| TW445937U (en) | Combination tool set | |
| ZA200003475B (en) | Muscarinic receptor antagonists. | |
| GB9801933D0 (en) | Combination square | |
| GB9811283D0 (en) | Vironectin receptor antagonists | |
| ZA961293B (en) | Muscarinic antagonists | |
| GB9801657D0 (en) | Worktable construction | |
| PL341899A1 (en) | Vla-4 antagonists | |
| AU135297S (en) | Top |